NCT05998135 2025-09-11
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Emory University
Phase 2 Recruiting
Clinical Trials
6 trialsNCT06266091 2025-07-20
Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody
Wuhan YZY Biopharma Co., Ltd.
Phase 2 Completed
NCT06432296 2025-07-20
Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody
Wuhan YZY Biopharma Co., Ltd.
Phase 3 Active not recruiting
NCT04032600 2020-12-08
ATLANTIS
Charite University, Berlin, Germany
Phase NA Completed
NCT02441140 2020-05-04
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
Dana-Farber Cancer Institute
Phase NA Terminated
NCT00836654 2009-02-05
Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group
Neovii Biotech
Phase 2/3 Completed